Product Information
BEPOTASTINE 1.5% EYE DROP is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $11.2533 per ML under NDC 00378705535. Its NADAC has been published 262 times since Aug 18, 2021.
FDA first approved this application on Mar 18, 2019. Its Orange Book therapeutic-equivalence code is AT.
Strength
15 mg/mL
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378705535
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
BEPOTASTINE BESILATEApproval Type
Generic (ANDA)
FDA Application
ANDA206220FDA Approved
3/18/2019
TE Code
AT
On Market Since
5/28/2021
Pharmacological Classes
Price Statistics
The NADAC for BEPOTASTINE 1.5% EYE DROP has been published 262 times since Aug 18, 2021, and over the history we have for it it has declined 70.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.2533 per ML |
|---|---|
| All-time high | $38.6198 (Dec 15, 2021) |
| All-time low | $11.2533 (Aug 19, 2026) |
| 52-week high | $14.6605 |
| 52-week low | $11.2533 |
| Median price | $18.9364 |
| Average price | $20.7047 |
| Largest weekly change | +49.6% (Nov 20, 2024) |
| Weeks tracked | 262 |
| Tracking since | Aug 18, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 26% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BEPOTASTINE 1.5% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for BEPOTASTINE 1.5% EYE DROP, manufactured by Mylan Pharmaceuticals Inc., is $11.2533 per ML (NDC 00378705535), effective Aug 19, 2026.
How has the price of BEPOTASTINE 1.5% EYE DROP changed over time?
Over the history we have for it, the NADAC for BEPOTASTINE 1.5% EYE DROP has declined 70.6%. It has been tracked across 262 weekly CMS publications since Aug 18, 2021.
What are the highest and lowest recorded NADAC prices for BEPOTASTINE 1.5% EYE DROP?
Since Aug 18, 2021, the NADAC for BEPOTASTINE 1.5% EYE DROP has ranged from a low of $11.2533 (Aug 19, 2026) to a high of $38.6198 (Dec 15, 2021), with a median of $18.9364 per ML.
Are there cheaper alternatives to BEPOTASTINE 1.5% EYE DROP?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BEPOTASTINE 1.5% EYE DROP, is $8.3591 per ML — about 26% below BEPOTASTINE 1.5% EYE DROP.
Who manufactures BEPOTASTINE 1.5% EYE DROP?
BEPOTASTINE 1.5% EYE DROP (NDC 00378705535) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.